SAN DIEGO, Nov. 7, 2024 /PRNewswire/ -- Immunovia (NASDAQ STOCKHOLM: IMMNOV), the pancreatic cancer diagnostics company, will present an update on its next-generation test at the annual meeting of the ...
NEW CITY, N.Y., December 8, 2023 (Newswire.com) - The Pancreatic Cancer Early Detection (PRECEDE) Consortium, a beacon of hope in the global fight against pancreatic cancer, hosted its fifth annual ...
A new spinout from Dana-Farber Cancer Institute aims to deliver a series of blood tests aimed not only at directing patients to precision tumor treatments, but also at assisting drug developers in ...
Precede Biosciences Inc. emerged from stealth having raised $57 million in seed and series A financing to fund its genome-wide platform. The blood-based platform detects and provides critical insight ...
SAN DIEGO, Nov. 7, 2024 /PRNewswire/ -- Immunovia (NASDAQ STOCKHOLM: IMMNOV), the pancreatic cancer diagnostics company, will present an update on its next-generation test at the annual meeting of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback